| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
AJP - Regulatory, Integrative and Comparative Physiology, Vol 271, Issue 1 303-R309, Copyright © 1996 by American Physiological Society
ARTICLES |
H. Murakami, J. L. Liu and I. H. Zucker
Department of Physiology and Biophysics, University of Nebraska College of Medicine, Omaha 68198-4575, USA.
Because the renin-angiotensin system is activated in heart failure, we hypothesized that angiotensin II (ANG II) plays a role in altering baroreflex sensitivity in the setting of heart failure. Accordingly, we evaluated the baroreflex control of heart rate (HR) in conscious, chronically instrumented rabbits in the normal state and after the establishment of heart failure. Heart failure was induced by rapid ventricular pacing at a rate of 360-380 beats/min for an average of 14.5 +/- 1.4 days. The data were compared with normal rabbits instrumented in a similar fashion. Baroreflex curves were generated by inflation of implanted hydraulic occluders on the vena cava and aortic arch or by administration of phenylephrine and sodium nitroprusside. Experiments were carried out before and after intravenous administration of the AT1 antagonist L-158,809. Rabbits with heart failure exhibited significantly lower arterial pressure (81 +/- 3 vs. 69 +/- 4 mmHg, P < 0.05), elevated resting HR (230 +/- 5 vs. 260 +/- 10 beats/min, P < 0.05), and elevated left atrial pressure (3.6 +/- 0.7 vs. 13.1 +/- 0.7 mmHg, P < 0.05). ANG II blockade had little effect on resting or baroreflex parameters in normal rabbits. However, in rabbits with heart failure, L-158,809 enhanced baroreflex sensitivity (2.7 +/- 0.5 vs. 4.7 +/- 0.8 beats.min-1.mmHg-1; P < 0.05), primarily by increasing the minimum HR evoked during baroreceptor activation. beta 1-Blockade had no effect on any baroreflex parameter after L-158,809 in rabbits with heart failure. However, L-158,809 significantly reduced the minimum HR after pretreatment with atropine in rabbits with heart failure. These data suggest that ANG II plays a role in modulation of cardiac sympathetic tone in this model of heart failure and may be responsible for the depressed baroreflex sensitivity observed in heart failure.
This article has been cited by other articles:
|
|
 |
|
  A. M. D. Watson, S. G. Hood, R. Ramchandra, R. M. McAllen, and C. N. May Increased cardiac sympathetic nerve activity in heart failure is not due to desensitization of the arterial baroreflex Am J Physiol Heart Circ Physiol, July 1, 2007; 293(1): H798 - H804. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G.-Q. Zhu, K. P. Patel, I. H. Zucker, and W. Wang Microinjection of ANG II into paraventricular nucleus enhances cardiac sympathetic afferent reflex in rats Am J Physiol Heart Circ Physiol, June 1, 2002; 282(6): H2039 - H2045. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Shigematsu, Y. Hirooka, K. Eshima, M. Shihara, T. Tagawa, and A. Takeshita Endogenous angiotensin II in the NTS contributes to sympathetic activation in rats with aortocaval shunt Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2001; 280(6): R1665 - R1673. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Kawai, S. Y. Stevens, and C.-S. Liang Renin-angiotensin system inhibition on noradrenergic nerve terminal function in pacing-induced heart failure Am J Physiol Heart Circ Physiol, December 1, 2000; 279(6): H3012 - H3019. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J.-L. Liu, H. Murakami, M. Sanderford, V. S. Bishop, and I. H. Zucker ANG II and baroreflex function in rabbits with CHF and lesions of the area postrema Am J Physiol Heart Circ Physiol, July 1, 1999; 277(1): H342 - H350. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
W. Zhang, B. S. Huang, and F. H. H. Leenen Brain renin-angiotensin system and sympathetic hyperactivity in rats after myocardial infarction Am J Physiol Heart Circ Physiol, May 1, 1999; 276(5): H1608 - H1615. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-Y. Sun, W. Wang, I. H. Zucker, and H. D. Schultz Enhanced peripheral chemoreflex function in conscious rabbits with pacing-induced heart failure J Appl Physiol, April 1, 1999; 86(4): 1264 - 1272. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S.-Y. Sun, W. Wang, I. H. Zucker, and H. D. Schultz Enhanced activity of carotid body chemoreceptors in rabbits with heart failure: role of nitric oxide J Appl Physiol, April 1, 1999; 86(4): 1273 - 1282. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-L. Liu and I. H. Zucker Regulation of Sympathetic Nerve Activity in Heart Failure : A Role for Nitric Oxide and Angiotensin II Circ. Res., March 5, 1999; 84(4): 417 - 423. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
R. Willenbrock, H. Stauss, M. Scheuermann, K. J. Osterziel, T. Unger, and R. Dietz Effect of chronic volume overload on baroreflex control of heart rate and sympathetic nerve activity Am J Physiol Heart Circ Physiol, December 1, 1997; 273(6): H2580 - H2585. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. Murakami, J.-L. Liu, and I. H. Zucker Angiotensin II Enhances Baroreflex Control of Sympathetic Outflow in Heart Failure Hypertension, February 1, 1997; 29(2): 564 - 569. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |
